BRIEF-EMA Recommends Against Approval Of Puma Biotechnology's Breast Cancer Drug Neratinib By: Reuters: Company News February 23, 2018 at 07:15 AM EST * EU MEDICINES AGENCY RECOMMENDATIONS FOR FEBRUARY 2018 BREAST CANCER DRUG NERATINIB Read More >> Related Stocks: Pfizer Puma Biotechnology